InvestorsHub Logo
Followers 0
Posts 484
Boards Moderated 0
Alias Born 10/10/2014

Re: Oren1976 post# 817

Tuesday, 04/18/2017 12:36:51 PM

Tuesday, April 18, 2017 12:36:51 PM

Post# of 2099
It's not bad that a useless drug has peak sales of $7 to $9 billion. I wish VB-111 becomes that "useless" ... lol.

All kidding aside, one thing to note is that avastin's US patent is expiring in 2019 so the clock is ticking for Roche. If VB-111 gets positive interim then I can see Roche and AZ taking a very strong look at VBL.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VBLT News